Gene expression profile helps predict chemotherapy response in ovarian cancer patients
A newly identified gene expression profile could help predict how patients with advanced ovarian cancer will respond to chemotherapy treatment. Described in a study in the November 1, 2005 issue of The Journal of Clinical Oncology (JCO), the new findings further establish an important role for microarray gene profiling as a predictor of clinical outcome in ovarian cancer, and could eventually provide clinicians with insights into the mechanisms of drug resistance.
HIV-positive patients have shorter survival periods while awaiting liver transplants
A new study on HIV-positive patients eligible for liver transplants found that their survival while waiting for a transplant is significantly shorter than patients who are HIV-negative. Other than infection, which caused many of the deaths, there appear to be no other factors that predict a poor outcome for these patients. more
Compound in wine reduces levels of Alzheimer's disease-causing peptides
A study published in the November 11 issue of the Journal of Biological Chemistry shows that resveratrol, a compound found in grapes and red wine, lowers the levels of the amyloid-beta peptides which cause the telltale senile plaques of Alzheimer's disease. more
UK Doctors advised to plan their response to flu pandemic
Family doctors are advised to plan their response to managing a flu pandemic in this week's BMJ.
The advice is based on a module that is freely available on BMJ Learning (www.bmjlearning.com) to help keep health professionals up to date with key issues. more
Researchers looking at how neighborhoods contribute to healthy lifestyles
Families living in the Nellies Cave Park area near Virginia Tech are helping researchers learn about healthy lifestyles and in return are getting information about their own health. more
Headlines about Herceptin show equality of access to costly drugs must be tackled
The recent press coverage on the use of Herceptin (brand name for the drug trastuzumab) for treating breast cancer in its early stages shows that issues of equal access to costly but effective drugs must be confronted, says an editorial in this week's BMJ. more
Should doctors tell patients about expensive, unfunded drugs?
It is unethical and paternalistic for doctors to withhold information from patients about new drugs that are not yet publicly funded, say researchers in this week's BMJ. more